Acceptable Use Policy

Eligible buyers

Only qualified researchers acting on behalf of a professional research institution established in an eligible European Union member state, as defined in the Research-Use Policy, may place orders. Individuals acting in a personal capacity are not eligible buyers and must not attempt to create an account.

Eligible uses

Substances supplied by endopep may be used only for in-vitro laboratory research conducted in a controlled laboratory environment, consistent with the buyer's institutional research programme, and in compliance with the Safety Data Sheet and with all applicable laws of the buyer's jurisdiction.

Prohibited uses

The following uses are expressly prohibited, without exception: administration to any human being by any route, including oral, nasal, subcutaneous, intramuscular, intravenous, topical, sublingual, inhaled, rectal, ophthalmic, or any other route; administration to any animal; preparation of any formulation, compounded product, or finished product intended for human or veterinary administration; use as a food, food ingredient, food supplement or dietary supplement; use as a cosmetic or cosmetic ingredient; use as a medicinal product, diagnostic agent or medical device; resale, re-supply, transfer or gift to any person or entity outside the buyer's institution for any of the prohibited uses; re-export outside the European Union eligible-country list; any use that would require a marketing authorisation, clinical-trial authorisation, or other regulatory authorisation that the buyer does not hold; any use in breach of national or EU controlled-substances, novel-food, cosmetic, medicinal-product or chemicals law.

Handling obligations

The buyer must read the Safety Data Sheet before handling any substance, must handle every substance in a controlled laboratory environment with appropriate personal protective equipment, and must dispose of unused substance and contaminated materials in accordance with local waste-management requirements.

Reporting obligations

If the buyer becomes aware of any adverse event, accidental exposure, or suspected misuse affecting any person, the buyer must notify endopep in writing at support@endopep.com within 24 hours of becoming aware, regardless of whether the event involves the buyer's own personnel or a third party. endopep may be required to escalate such reports to a national competent authority.

Consequences of breach

Any breach or suspected breach of this Acceptable Use Policy is a material breach of the Terms of Supply. On breach, endopep may, in its absolute discretion and without liability: refuse, cancel, or delay any pending or future order; suspend or terminate the buyer's account; disable the buyer's institution; demand return of any supplied substance; report the breach to national competent authorities, to payment-processing partners, and to other relevant third parties; and pursue any legal remedy available under the Terms of Supply and applicable law. The Indemnity clause in the Terms of Supply applies to every breach.

Reporting a breach

Anyone with information about a breach of this Acceptable Use Policy, including misuse of any substance supplied by endopep, is asked to contact support@endopep.com. Reports may be made anonymously. endopep investigates every report and takes action proportionate to the findings.